Progress in pancreas transplantation and combined pancreas-kidney transplantation

Hepatobiliary and Pancreatic Diseases International

Volumn 6, Issue 1, 2007, Pages 17-23

  Ming, Chang Sheng ^a   Klaus Chen, Zhong Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bladder drainage; Diabetes mellitus; Enteric drainage; Immunosuppression; Pancreas transplantation; Portal drainage

Indexed keywords

ALEMTUZUMAB; ANTIMETABOLITE; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; INSULIN; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; POLYCLONAL ANTIBODY; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

AGE DISTRIBUTION; BALANITIS; BLADDER STONE; BODY WEIGHT; CHEMICAL CYSTITIS; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE COST; HEMATURIA; HUMAN; HYPERINSULINEMIA; HYPONATREMIA; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; KIDNEY DISEASE; KIDNEY PANCREAS TRANSPLANTATION; MAINTENANCE THERAPY; MEDLINE; METABOLIC ACIDOSIS; OPPORTUNISTIC INFECTION; ORAL GLUCOSE TOLERANCE TEST; PANCREAS TRANSPLANTATION; PANCREATITIS; PROSTATITIS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SIDE EFFECT; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; URETHRA STRICTURE; URINARY TRACT INFECTION; URINE INCONTINENCE; VESICOURETERAL REFLUX;

DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PANCREAS; PANCREAS TRANSPLANTATION; TREATMENT OUTCOME;

EID: 33846987921     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Gruessner A, Sutherland DE. Pancreas transplantation in the United States (US) and non-US as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Clin Transpl 1996;:47-67.
2. Burke GW, Ciancio G, Sollinger HW. Advances in pancreas transplantation. Transplantation 2004;77(9 Suppl):62-67.
3. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005;19:433-455.
4. Odorico, JS, Sollinger HW. Technical and immunosuppressive advances in transplantation for insulin-dependent diabetes mellitus. World I Surg 2002;26:194-211. Epub 2001 Dec 17.
5. Orsenigo E, Socci C, Fiorina P, Cristallo M, Castoldi R, Gavazzi F, et al. Simultaneous pancreas-kidney transplantation: short- and long-term results. Transplant Proc 2004;36:586-588.
6. Drognitz O, Benz S, Pfeffer F, Fischer C, Makowiec F, Schareck W, et al. Long-term follow-up of 78 simultaneous pancreas-kidney transplants at a single-center institution in Europe. Transplantation 2004;78:1802-1808.
7. Sutherland DE, Gruessner RW, Dunn DL, Matas Al, Humar A, Kandaswamy R, et al. Lessons learned from more than 1000 pancreas transplants at a single institution. Ann Surg 2001;233:463-501.
8. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of May 2003. Clin Transpl 2003;:21-51.
9. Hariharan S, Pirsch JD, Lu CY, Chan L, Pesavento TE, Alexander S, et al. Pancreas after kidney transplantation. J Am Soc Nephrol 2002;13:1109-1118.
10. Ming CS. Clinical advances of pancreas transplantation alone and combined pancreas and kidney transplantation. Urol Nephrol Foreign Med Sci 2005;25: 775-778.
11. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 1967;61:827-837.
12. Lillehei RC, Simmons RL, Najarian JS, Weil R, Uchida H, Ruiz JO, et al. Pancreatico -duodenal allotransplantation: experimental and clinical experience. Ann Surg 1970;172: 405-436.
13. Calne RY. Paratopic segmental pancreas grafting: a technique with portal venous drainage. Lancet 1984;1:595-597.
14. Gliedman ML, Gold M, Whittaker J, Rifkin H, Soberman R, Freed S, et al. Clinical segmental pancreatic transplantation with ureter-pancreatic duct anastomosis for exocrine drainage. Surgery 1973;74:171-180.
15. Dubernard JM, Traeger J, Neyra P, Touraine JL, Tranchant D, Blanc-Brunat N. A new method of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man. Surgery 1978;84:633-639.
16. Sutherland DE, Goetz FC, Najarian JS. Intraperitoneal transplantation of immediately vascularized segmental pancreatic grafts without duct ligation. A clinical trial. Transplantation 1979;28:485-491.
17. Cook K, Sollinger HW, Warner T, Kamps D, Belzer FO. Pancreaticocystostomy: an alternative method for exocrine drainage of segmental pancreatic allografts. Transplantation 1983;35:634-636.
18. Sollinger HW, Cook K, Kamps D, Glass NR, Belzer FO. Clinical and experimental experience with pancreaticocystostomy for exocrine pancreatic drainage in pancreas transplantation. Transplant Proc 1984;16:749-751.
19. Di Carlo A, Odorico JS, Sollinger HW. Pancreas transplantation: an overview. Transplantation Reviews 2004;18:1-9.
20. van der Boog PJM, Ringers J, Paul LC, Jukema JW, Baranski A, Lemkes HHPJ, et al. Simultaneous kidney-pancreas transplantation: the preferred option for patients with type I diabetes mellitus and approaching end-stage renal disease. Transplantation Reviews 2004;18:129-138.
21. Blanchet P, Droupy S, Eschwege P, Hammoudi Y, Durrbach A, Charpentier B, et al. Urodynamic testing predicts long-term urological complications following simultaneous pancreas-kidney transplantation. Clin Transplant 2003;17: 26-31.
22. Black PC, Plaskon LA, Miller J, Bakthavatsalarn R, Kuhr CS, Marsh CL. Cystoenteric conversion and reduction cystoplasty for treatment of bladder dysfunction after pancreas transplantation. J Urol 2003;170:1913-1917.
23. Martin X, Badet L, Dubernard JM. Recent technical aspects in pancreas transplantation. Curr Opin Organ Transplant 2004;9:82-85.
24. Boggi U, Vistoli F, Signori S, Del Chiaro M, Campatelli A, Di Candio G, et al. Surveillance and rescue of pancreas grafts. Transplant Proc 2005;37:2644-2647.
25. Henry ML. The case against less rejection with portal venous drainage and pancreas transplantation. Transplant Proc 2002;34:1899-1900.
26. Philosophe B. Portal versus systemic delivery of insulin: immunologic benefits for pancreas transplantation. Curr Opin Organ Transplant 2002;7:180-184.
27. Philosophe B, Farney AC, Schweitzer EJ, Colonna JO, Jarrell BE, Krishnamurthi V, et al. Superiority of portal venous drainage over systemic venous drainage in pancreas transplantation: a retrospective study. Ann Surg 2001;234:689-696.
28. Petruzzo P, Konan PG, Feitosa LC, Da Silva M, Touiti D, Lefrancois N, et al. A randomized trial in simultaneous pancreas-kidney transplantation: portal versus systemic venous drainage of the pancreas allograft. Transplant Proc 2000;32:2776-2777.
29. Tyden G, Tollemar J, Bolinder J. Combined pancreas and kidney transplantation improves survival in patients with end-stage diabetic nephropathy. Clin Transplant 2000;14:505-508.
30. Becker BN, Brazy PC, Becker YT, Odorico JS, Pintar TJ, Collins BH, et al. Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int 2000;57:2129-2135.
31. Smets YF, Westendorp RG, van der Pijl JW, de Charro FT, Ringers J, de Fijter JW, et al. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999;353:1915-1919.
32. Lo A, Stratta RJ, Hathaway DK, Egidi MF, Shokouh-Amiri MH, Grewal HP, et al. Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage. Transplant Proc 2001;33:1684-1686.
33. Gaber LW, Egidi MF, Gaber AO. An ideal nondiabetogenic, nonnephrotoxic immunosuppressive protocols for pancreas transplantation. Curr Opin Organ Transplant 2003;8:186-189.
34. Kaufman DB, Salvalaggio PRD. Immunosuppression for pancreas transplantation. Curr Opin Organ Transplant 2005;10:169-175.
35. Kaufman DB, Shapiro R, Lucey MR, Cherikh WS, T Bustami R, Dyke DB. Immunosuppression: practice and trends. Am J Transplant 2004;4(Suppl 9):38-53.
36. Malaise J, Saudek F, Boucek P, Adamec M, Van Ophem D, Squifflet JP, et al. Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: the EURO-SPK 3-year results. Transplant Proc 2005;37:2843-2845.
37. Mark W, Berger N, Lechleitner M, Rosenkranz A, Margreiter R, Steurer W, et al. Impact of steroid withdrawal on metabolic parameters in a series of 112 enteric/systemic-drained pancreatic transplants. Transplant Proc 2005;37:1821-1825.
38. Bechstein WO, Malaise J, Saudek F, Land W, Fernandez-Cruz L, Margreiter R, et al. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial. Transplantation 2004;77:1221-1228.
39. Shapiro R, Jordan ML, Scantlebury VP, Vivas C, Fung JJ, McCauley J, et al. A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 1995;59:485-490.
40. Dieterle CD, Schmauss S, Veitenhansl M, Gutt B, Illner WD, Land W, et al. Glucose metabolism after pancreas transplantation: cyclosporine versus tacrolimus. Transplantation 2004;77:1561-1565.
41. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002;25:583-592.
42. Merion RM, Henry ML, Melzer JS, Sollinger HW, Sutherland DE, Taylor RJ. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation. Transplantation 2000;70:105-111.
43. Odorico JS, Pirsch JD, Knechtle SJ, D'Alessandro AM, Sollinger HW. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation. Transplantation 1998;66:1751-1759.
44. Knight RJ, Kerman RH, Zela S, Podder H, Van Buren CT, Katz S, et al. Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation. Transplantation 2003;75:1301-1306.
45. Kaufman DB, Leventhal JR, Koffron AJ, Gallon LG, Parker MA, Fryer JP, et al. A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: comparison of two maintenance immunosuppression protocols: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation 2002; 73:169-177.
46. Kaufman DB, Leventhal JR, Gallon LG, Parker MA, Elliott MD, Gheorghiade M, et al. Technical and immunologic progress in simultaneous pancreas-kidney transplantation. Surgery 2002;132:545-553; discussion 553-554.
47. Garcia VD, Keitel E, Santos AF, Bianco PD, Bittar AE, Bruno RM, et al. Immunosuppression in pancreas transplantation: mycophenolate mofetil versus sirolimus. Transplant Proc 2004;36:975-977.